Investment Advisory Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$355K Buy
296
+3
+1% +$3.06K 0.1% 93
2026
Q1
$270K Sell
293
-3
-1% -$3.04K 0.09% 106
2025
Q4
$318K Hold
296
0.1% 90
2025
Q3
$226K Sell
296
-36
-11% -$26.8K 0.07% 116
2025
Q2
$259K Buy
332
+10
+3% +$7.77K 0.09% 106
2025
Q1
$266K Hold
322
0.1% 100
2024
Q4
$248K Buy
322
+24
+8% +$19.9K 0.09% 104
2024
Q3
$264K Buy
298
+11
+4% +$9.89K 0.09% 102
2024
Q2
$260K Buy
287
+24
+9% +$19.2K 0.1% 100
2024
Q1
$204K Buy
+263
New +$187K 0.08% 114

Other funds holding LLY

Investment Advisory Services's LLY Position: Q2 2026 in Review

Investment Advisory Services increased its Eli Lilly (LLY) stake by 1% in Q2 2026, buying an estimated $3.06K and bringing the position to 296 shares worth $355K. The position accounts for 0.1% of the portfolio, ranked #93.

Investment Advisory Services first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Investment Advisory Services held 296 shares of Eli Lilly worth $355K as of Q2 2026.
  • Investment Advisory Services bought 3 Eli Lilly shares in Q2 2026, an estimated $3.06K.
  • Eli Lilly made up 0.1% of Investment Advisory Services's portfolio in Q2 2026, its #93 holding.
  • Investment Advisory Services first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Investment Advisory Services's 13F filing for Q2 2026, filed 14 Jul 2026.